XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed consolidated statements of operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Total revenue $ 7,205 $ 5,611
Costs and operating expenses:    
Research and development 3,624 3,842
Sales and marketing 2,751 3,281
General and administrative 5,690 5,627
Total costs and operating expenses 18,866 19,884
Loss from operations (11,661) (14,273)
Other income (expense):    
Interest income, net 466 983
Other expense, net (61) (29)
Total other income, net 405 954
Loss before income taxes (11,256) (13,319)
Income tax expense 7 3
Net loss $ (11,263) $ (13,322)
Net loss per share - basic (in dollars per share) $ (0.26) $ (0.31)
Net loss per share - diluted (in dollars per share) $ (0.26) $ (0.31)
Weighted average common shares outstanding - basic (in shares) 43,993,359 43,245,835
Weighted average common shares outstanding - diluted (in shares) 43,993,359 43,245,835
Product    
Revenue:    
Total revenue $ 4,101 $ 3,713
Costs and operating expenses:    
Cost of revenue 5,029 5,173
Service    
Revenue:    
Total revenue 3,104 1,898
Costs and operating expenses:    
Cost of revenue $ 1,772 $ 1,961